
-
Myanmar quake survivors plead for more help
-
Greece to spend 25 bn euros in 'drastic' defence overhaul: PM
-
Maresca non-committal over Sancho's future at Chelsea
-
WHO facing $2.5-bn gap even after slashing budget: report
-
Real Madrid coach Ancelotti tells tax trial did not seek to defraud
-
Chinese tourists pine for Taiwan's return as Beijing jets surround island
-
Singapore detains teenage boy allegedly planning to kill Muslims
-
What is the 'Qatargate' scandal roiling Israel?
-
AI coming for anime but Ghibli's Miyazaki irreplaceable, son says
-
Swedish insurer drops $160 mn Tesla stake over labour rights
-
Hunger returns to Gaza as Israeli blockade forces bakeries shut
-
Rubio heads to Europe as transatlantic tensions soar
-
Like 'living in hell': Quake-hit Mandalay monastery clears away rubble
-
'Give me a break': Trump tariffs threaten Japan auto sector
-
US approves $5.58 bn fighter jet sale to Philippines
-
Tsunoda embracing pressure of Red Bull debut at home Japanese GP
-
'Outstanding' Hay shines as New Zealand seal Pakistan ODI series
-
El Salvador's Bukele flaunts 'iron fist' alliance with Trump
-
Stock markets mixed as uncertainty rules ahead of Trump tariffs
-
China probes for key target weak spots with 'paralysing' Taiwan drills
-
'Top Gun' and Batman star Val Kilmer dies aged 65: New York Times
-
US lawmakers seek to rename street for Hong Kong's jailed Jimmy Lai
-
Greece to spend big on 'historic' military shake up
-
Trump faces first electoral setback after Wisconsin Supreme Court vote
-
Hay shines as New Zealand beat Pakistan for ODI series win
-
Israel says expands Gaza offensive to seize 'large areas'
-
Curry drops 52 as Warriors win, Jokic bags career-high 61 in Denver loss
-
South Korea mobilising 'all resources' for violence-free Yoon verdict
-
Myanmar quake victim rescued after 5 days as aid calls grow
-
Real Madrid coach Ancelotti tax fraud trial set to begin
-
Warner showcases 'Superman' reboot, new DiCaprio film
-
'Incredible' Curry scores 52 as Warriors down Grizzlies, Bucks edge Suns
-
Asian markets edge up but uncertainty rules ahead of Trump tariffs
-
Nintendo's megahit Switch console: what to know
-
Nintendo to unveil upgrade to best-selling Switch console
-
China practises hitting key ports, energy sites in Taiwan drills
-
Oil, sand and speed: Saudi gearheads take on towering dunes
-
All eyes on Tsunoda at Japan GP after ruthless Red Bull move
-
'Image whisperers' bring vision to the blind at Red Cross museum
-
Hay shines as New Zealand make 292-8 in Pakistan ODI
-
Other governments 'weaponising' Trump language to attack NGOs: rights groups
-
UK imposes online entry permit on European visitors
-
How a Brazilian chief is staving off Amazon destruction
-
Meme politics: White House embraces aggressive alt-right online culture
-
China launches military drills in Taiwan Strait
-
US senator smashes record with 25-hour anti-Trump speech
-
Brazil binman finds newborn baby on garbage route
-
US senator smashes record with marathon anti-Trump speech
-
Trump advisor Waltz faces new pressure over Gmail usage
-
Phoenix Motor and InductEV Launch the World's First Commercially Available, Wirelessly Charged Medium-Duty Electric Shuttle Bus

'Geneva patient' the latest in long-term remission from HIV
A man dubbed the "Geneva patient" is the latest person with HIV to be declared in long-term remission -- however he did not receive a transplant with a virus-blocking gene mutation like previous cases, researchers said Thursday.
Five people have previously been considered "cured" of HIV: the Berlin, London, Duesseldorf, New York and City of Hope, California patients.
All had bone marrow transplants to treat serious cases of cancer, receiving stem cells from a donor with a mutation of the CCR5 gene. This mutation is known to block HIV from entering the body's cells.
In 2018, the Geneva patient similarly received a stem cell transplant to treat a particularly aggressive form of leukaemia.
But this time the transplant came from a donor who did not carry the CCR5 mutation, French and Swiss researchers told a press conference in the Australian city of Brisbane as part of an AIDS conference that begins at the weekend.
This means that the virus is still able to enter the patient's cells.
However, 20 months after the man stopped taking antiretroviral treatment -- which reduces the amount of HIV in the blood -- doctors at Geneva University Hospitals have not found a trace of the virus in his system, the researchers said.
While they cannot rule out that the man's HIV will return, the researchers said they consider him to be in long-term remission.
"What is happening to me is magnificent, magical," the Geneva patient said in a statement.
The patient, a white man who chose not to be named, was diagnosed with HIV in 1990.
He had been on antiretrovirals until November 2021, when his doctors advised him to stop taking the treatment after the bone marrow transplant.
- 'Promising' -
Two previous cases, known as the Boston patients, had also received normal or "wild type" stem cells during their transplants. But in both cases, HIV returned a few months after they stopped taking antiretrovirals.
Asier Saez-Cirion, a scientist at France's Pasteur Institute who presented the Geneva patient case in Brisbane, told AFP that if there was still no sign of the virus after 12 months "the probability that it will be undetectable in the future increases significantly".
There were a couple of possible explanations for why the Geneva patient remains HIV free, Saez-Cirion said.
"In this specific case, perhaps the transplant eliminated all the infected cells without the need for the famous mutation," he said.
"Or maybe his immunosuppressive treatment, which was required after the transplant, played a role."
Sharon Lewin, the president of the International AIDS Society holding the HIV science conference in Brisbane, said the case was "promising".
"But we learned from the Boston patients that even a single" particle of the virus can lead to HIV rebounding, she cautioned.
"This particular individual will need to be watched closely over the next months and years."
While these cases of long-term remission raise hopes that one day HIV can truly be cured, the brutal and risky bone marrow transplant procedure is not an option for the millions of people living with the virus around the world.
It is instead a last-ditch attempt to treat life-threatening cancer in people who also have HIV.
However, there are hopes that the remission cases could point towards new avenues of research, such as the potential role played by immunosuppressive treatments.
Saez-Cirion said the case had also encouraged the researchers to continue studying innate immune cells, which act as the first line of defence against various pathogens, and could help control the virus.
For his part, the Geneva patient said he was now "looking to the future".
M.A.Colin--AMWN